|
ANKRD12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.82070000000123E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.15780000000821E-05 |
| Normal-vs-Stage2 |
9.371600E-04 |
| Normal-vs-Stage3 |
7.953900E-04 |
| Normal-vs-Stage4 |
1.812950E-04 |
| Stage1-vs-Stage2 |
6.773800E-01 |
| Stage1-vs-Stage3 |
5.775400E-01 |
| Stage1-vs-Stage4 |
8.566200E-02 |
| Stage2-vs-Stage3 |
9.454000E-01 |
| Stage2-vs-Stage4 |
3.827800E-01 |
| Stage3-vs-Stage4 |
4.735400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26289999999407E-05 |
| Normal-vs-AfricanAmerican |
1.796180E-03 |
| Normal-vs-Asian |
5.92419999723148E-08 |
| Caucasian-vs-AfricanAmerican |
5.653600E-01 |
| Caucasian-vs-Asian |
1.484600E-03 |
| AfricanAmerican-vs-Asian |
5.612300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.69249999999855E-05 |
| Normal-vs-Female |
1.203770E-02 |
| Male-vs-Female |
4.318100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.003800E-03 |
| Normal-vs-Extreme_Weight |
2.43709999999675E-05 |
| Normal-vs-Obese |
1.038840E-03 |
| Normal-vs-Extreme_Obese |
2.304100E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.337800E-01 |
| Normal_Weight-vs-Obese |
8.295000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.793200E-01 |
| Extreme_Weight-vs-Obese |
1.628640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.523800E-01 |
| Obese-vs-Extreme_Obese |
3.977000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440260E-02 |
| Normal-vs-Age(41-60Yrs) |
3.476800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.58579999998132E-06 |
| Normal-vs-Age(81-100Yrs) |
2.377500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.948800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.488200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.188200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.336100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.004400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.355800E-04 |
| Normal-VS-Type2 PRCC |
5.74670000030864E-07 |
| Normal-VS-KIRP CIMP |
2.561900E-03 |
| Normal-VS-Unclassified PRCC |
6.658000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.320500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.282400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.935600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.978800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.928000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.380800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20230000399957E-08 |
| Normal-vs-N1 |
2.621000E-03 |
| Normal-vs-N2 |
2.937500E-03 |
| N0-vs-N1 |
1.206190E-01 |
| N0-vs-N2 |
3.919800E-01 |
| N1-vs-N2 |
2.169200E-01 |
|
|
